China has issued two State Council decrees that further develop its legal and institutional framework for responding to foreign measures applied on an extraterritorial basis and for safeguarding the security of industrial and supply chains. Both decrees operate alongside existing instruments, including the Anti‑Foreign Sanctions Law (“AFSL“), China’s…
Baker McKenzie’s Trade, Sanctions, and Customs Practice is pleased to invite you to our 2026 Global Trade and Customs Webinar Series. This series includes a variety of sessions spread throughout the year, addressing the latest developments in trade and customs compliance. In these sessions, our panel of international…
President Trump has issued an Executive Order (the Order) directing the Department of Justice (DOJ) and Federal Trade Commission (FTC) to launch investigations into the U.S. food sector, focusing on potential price-fixing, other forms of criminal collusion, and non-criminal anticompetitive conduct. The Order creates new Food Supply Chain…
Tariffs and shifting trade dynamics continue to disrupt healthcare and life sciences supply chains. But in addition to affecting operational and commercial outlooks for business, they are also revealing new opportunities for innovators and investors. In the final article of the series, we explore five key questions:
As supply chains shift and vendor arrangements evolve in response to tariffs, life sciences companies must adapt to increasingly intricate and intertwined challenges across operational and commercial needs. Manufacturing relocation, technology adoption, and new vendor partnerships require careful oversight of labor, compliance, human rights, and union matters. Protecting…